Iimpawu zeBiomarkers ze-Chronic Atrophic Gastritis: Uphando oluPhambili
I-Chronic Atrophic Gastritis (CAG) sisifo esiqhelekileyo sesisu esingapheliyo esibonakaliswa kukulahlekelwa kancinci kancinci kwe-mucosal glands yesisu kunye nokuncipha kokusebenza kwesisu. Njengenqanaba elibalulekileyo lezilonda zesisu ngaphambi komhlaza, ukuxilongwa kwangoko kunye nokubekwa esweni kwe-CAG kubalulekile ekuthinteleni uphuhliso lomhlaza wesisu. Kweli phepha, siza kuxoxa ngeempawu eziphambili zangoku ezisetyenziselwa ukuxilonga nokubeka esweni i-CAG kunye nexabiso layo lesicelo seklinikhi.
I. Ii-Serologic BioMarkers
- I-Pepsinogen (PG)IPGⅠ/PGⅡ umlinganiselo (PGⅠ/PGⅡ) yeyona nto isetyenziswa kakhulu kwi-serologic marker ye-CAG.
- Amanqanaba anciphileyo I-PGⅠ kunye ne-PGⅠ/PGⅡUmlinganiselo unxulumene kakhulu nomlinganiselo wokuwohloka komzimba wesisu.
- Izikhokelo zaseJapan nezaseYurophu zibandakanye uvavanyo lwe-PG kwiinkqubo zokuhlola umhlaza wesisu
- Ibonisa imeko yokusebenza kwe-endocrine ye-sinus yesisu.
- Ukuncipha kokubola kwesisu esiswini kwaye kunokwanda ukubola komzimba wesisu.
- Idityaniswe ne-PG ukuphucula ukuchaneka kokuxilonga kwe-CAG
3. Ii-Anti-Parietal Cell Antibodies (APCA) kunye nee-Anti-Intrinsic Factor Antibodies (AIFA)
- Iimpawu ezithile ze-autoimmune gastritis.
- Iluncedo ekwahlukaniseni isifo se-autoimmune gastritis kwezinye iintlobo ze-CAG
2. Iibhayomarker zeHistological
- I-CDX2 kunye ne-MUC2
- Imolekyuli ephawulekayo ye-chemotaxis yamathumbu
- Ukunyuka kwesisu kubonisa ukuba isisu siqala ukubila.
- p53 kunye neKi-67
- Izalathisi zokwanda kweeseli kunye nokwahlukana okungaqhelekanga.
- Nceda uvavanye umngcipheko womhlaza kwi-CAG.
- I-Helicobacter pylori (H. pylori)-Iimpawu eziNxulumeneyo
- Ukufunyanwa kwezinto ezibangela ubungozi njengeCagA kunye neVacA.
- Uvavanyo lokuphefumla lwe-urea (UBT) kunye novavanyo lwe-antigen yestool.
3. Ii-Biomarkers zeMolekyuli ezisakhulayo
- ii-microRNA
- i-miR-21, i-miR-155 kunye nezinye zibonakaliswa ngendlela engaqhelekanga kwi-CAG
- Ixabiso elinokubakho lokuxilongwa kunye nelokuxela kwangaphambili.
- Iimpawu zeMethylation zeDNA
- Iipateni ze-methylation ezingaqhelekanga kwiindawo ezikhuthazayo zezakhi ezithile zemfuza
- Isimo seMethylation seejini ezifana neCDH1 kunye neRPRM
- Iimpawu zeMetabolomic Biomarkers
- Utshintsho kwiiprofayili ezithile ze-metabolite lubonisa imeko ye-mucosa yesisu
- Iingcamango ezintsha zokuxilongwa okungengongeneleli
4. Izicelo zeKlinikhi kunye neeMbono zeXesha elizayo
Uvavanyo oludibeneyo lwee-biomarkers lunokuphucula kakhulu ubuntununtunu kunye nokuchaneka kokuxilongwa kwe-CAG. Kwixesha elizayo, uhlalutyo oludibeneyo lwe-multi-omics kulindeleke ukuba lubonelele ngokudibanisa okubanzi ngakumbi kwee-biomarkers zokubhala ngokuchanekileyo, ukwahlulwahlulwa komngcipheko kunye nokubekwa esweni kwe-CAG ngabanye.
Thina iBaysen Medical sigxile kuphando nophuhliso lwezinto ezibangela ukuxilonga izifo zenkqubo yokugaya ukutya, kwaye siye saphuhlisaPGⅠ, PGⅡ kwayeG-17 Iikiti zovavanyo ezisekwe ngokubambisana ezinobuntununtunu obuphezulu kunye nokuchaneka, ezinokubonelela ngezixhobo zokuhlola ezithembekileyo ze-CAG kwiklinikhi. Siza kuqhubeka nokulandela inkqubela yophando kweli candelo kwaye sikhuthaze ukusetyenziswa koguqulelo lweempawu ezintsha ngakumbi.
Ixesha lokuthumela: Juni-30-2025






